Positive Effect of Alendronate on Subchondral Bone Healing and Subsequent Cartilage Repair in a Rabbit Osteochondral Defect Model
Background Cartilage and subchondral bone have recently been considered an osteochondral unit. The treatment of osteochondral lesions is still challenging, but better subchondral bone repair may result in higher quality repaired cartilage. Hypotheses Alendronate accelerates bone formation in osteoch...
Gespeichert in:
Veröffentlicht in: | The American journal of sports medicine 2009-11, Vol.37 (1 suppl), p.139S-147 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background Cartilage and subchondral bone have recently been considered an osteochondral unit. The treatment of osteochondral lesions
is still challenging, but better subchondral bone repair may result in higher quality repaired cartilage.
Hypotheses Alendronate accelerates bone formation in osteochondral defects and affects the quality of the repaired cartilage.
Study Design Controlled laboratory study.
Methods Osteochondral defects were made on the left trochleas of 50 rabbits, which were assigned to 1 of 3 groups: control, ALN (weekly
subcutaneous injection of 0.14 mg/mL alendronate), and ALN-S (alendronate injection in the first 8 weeks only). They were
evaluated at 4, 8, 24, and 52 weeks. Bone repair was evaluated with microcomputed tomography and histologic evaluation. Cartilage
repair was evaluated with ultrasound and histologic analyses.
Results At 4 weeks, the defects were filled, and cartilage-like repair tissue was observed in the ALN group, whereas the defects
were incompletely filled in the control group. Alendronate treatment enhanced early bone formation and mineralization in the
osteochondral defect for the first 8 weeks. The continuous injection of alendronate for 24 weeks resulted in delayed bone
remodeling, but the rabbits in the ALN-S group showed good integrity of the subchondral bone plate, without delayed remodeling.
At 52 weeks, the ALN-S group had a columnar arrangement of chondrocytes that had less fibrillation and looked superior to
those in the ALN and control groups. Ultrasound analysis showed better quality of repaired cartilage of the ALN and ALN-S
group than the control group.
Conclusion Alendronate accelerated bone formation without inhibiting its mineralization but thereafter inhibited bone remodeling in
an osteochondral defect. The withdrawal of alendronate at 8 weeks avoided the delayed remodeling and showed better subchondral
bone repair. At 52 weeks, better subchondral bone repair resulted in better cartilage quality.
Clinical Relevance Alendronate administered in the early period accelerates bone formation and improves the quality of the repaired cartilage. |
---|---|
ISSN: | 0363-5465 1552-3365 |
DOI: | 10.1177/0363546509350984 |